Amitiza (lubiprostone) will come in a new lower strength for treating irritable bowel syndrome with constipation (IBS-C)

Amitiza (lubiprostone) will come in a new lower strength for treating irritable bowel syndrome with constipation (IBS-C).

It's the only drug approved for this condition now that Zelnorm (tegaserod) is restricted to emergency use only.

So far, this new indication is just for women...not men.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote